In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Dayaimi GonzálezPrograma de Doctorado en Ciencias Mención Biología Celular y Molecular Aplicada, Universidad de La Frontera, Temuco 4811230, Chile.ORCID 0009-0001-3924-6580 Andrés SantosCenter of Excellence in Translational Medicine-Scientific and Technology Bioresource Nucleus (CEMT- BIOREN), Faculty of Medicine, Universidad de La Frontera, Avenida Alemania N° 0458, Temuco 4780000, Chile.
Eulàlia Sans-SerramitjanaCenter of Excellence in Translational Medicine-Scientific and Technology Bioresource Nucleus (CEMT- BIOREN), Faculty of Medicine, Universidad de La Frontera, Avenida Alemania N° 0458, Temuco 4780000, Chile.ORCID 0000-0001-5642-6965 Fanny GuzmánCurauma Biotechnology Center, Pontificia Universidad Católica de Valparaíso, Valparaíso 2362807, Chile.ORCID 0000-0002-7829-0568 Carla Gallardo-BenaventeBiotechnology Center for Microbial Studies (CEBEM), Universidad de La Frontera, Temuco 4811230, Chile.ORCID 0000-0001-7293-517X Dayani HernándezDepartamento de Cirugía General, Facultad de Medicina de Mayabeque, Universidad de Ciencias Médicas de La Habana, Mayabeque 32000, Cuba.
Mercyleidi Díaz ReyesInstituto de Biología Molecular y Celular de Rosario (IBR-CONICET), Universidad Nacional de Rosario (UNR), Rosario 2000, Argentina.ORCID 0000-0002-7131-8468 Francisca AcevedoCenter of Excellence in Translational Medicine-Scientific and Technology Bioresource Nucleus (CEMT- BIOREN), Faculty of Medicine, Universidad de La Frontera, Avenida Alemania N° 0458, Temuco 4780000, Chile.ORCID 0000-0002-7060-0656 Funding
Agencia Nacional de Investigación y Desarrollo ANID-Milenio-NCN2023_054Agencia Nacional de Investigación y Desarrollo Grant Doctorado Nacional 21240305 for D.GAGROSUPER "Sinergia I+D Doctorados UFRO - Agrosuper"Universidad de La Frontera Support PP24-0019
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antimicrobial PeptidesGenome, BacterialRhodococcusAntarctic RegionsAnti-Bacterial AgentsBiofilmsMicrobial Sensitivity TestsMultigene FamilyPhylogenyAnti-Bacterial AgentsAntimicrobial Peptidesantibiofilm activityextremophilic microorganismsnonribosomal peptide synthetasesphylogenomic analysissecondary metabolite biosynthesis
Identifiers
PMID42589312
PMCPMC13467173
What OpenQuestion holds
Textmetadata
Read underepoch 390